3Halliwell RF, Davery PG, Lambert JJ. Antagonism of GABA receptor by 4-quinolones[J]. J Antimicrob Chemother, 1993, 31: 457.
4Domagala JM. Structure-activity and structure-side-effect relationships for quinolone antibacterials [J]. J Antimicroh Chemother, 1994, 23: 685.
5William PD, Helton DR. The proconvulsive activity of quinolone antibiotics in an animal model [J]. Toxicol Lett, 1991, 58: 21.
6Schmuck G, Schurmann A, Schluter G, et al. Determination of the excitatory potencyes of different fluoroquinolones in the central nervous system by an in vitro model[J]. Antimicrob Agents Chemother, 1998, 42 :1831.
7Hod S, Shimida J, Sato A, et al. Comparison of the inhibitory effects of new quinolone on gamma-aminobu-tyric acid receptor binding in the presence of anti-inflammatory drugs[J]. Rev Infect Dis, 1989, ( Suppl 5 ) :S1397.
8Robinstein E, Camm J. Cardiotoxicity of fluoroquinolones[J]. J Antimicrob Chemother, 2002,49: 593.
9Hagiwara T, Satch S, Kasai Y, et al. A comparative study of the fluoroquinolone antibacterial agents on the action potential duration in guinea pig ventricular myocardia[J]. Jpn J Pharmacol, 2001,87: 231.
10Anderson ME, Mazur A, Yang T, et al, Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotic [J]. J Pharmacol Exp Ther, 2001, 296: 806.
